Providers who treat people with diabetes have observed the phenomenon of low-income patients who need a lot of medical care not having enough information to choose policies that meet their needs.
A study published this week in a major diabetes journal has confirmed what physicians have been sharing in sessions at medical conferences in recent years: the rise of high-deductible plans is changing the behavior of those with diabetes and limited means, causing them to cut corners with some care.
The past 2 meetings of the American Diabetes Association Scientific Sessions have been marked by stories of patients deferring care, about struggles to pay for insulin, and by tales of interruptions in the Medicare supply chain for diabetes test strips, which CMS denies in a recent report to the Government Accountability Office.
ADA’s journal, Diabetes Care, found that complaints about the test strip availability had validity in a study published earlier this year, and this week’s study finds evidence to support other complaints.
Led by David L. Rabin, MD, MPH, the study used data from the 2011-2013, Medical Expenditure Panel Survey to evaluate demographic status, medical service use, and health status among all privately insured adults with diabetes aged 18 to 64 years. They were grouped according to those who were below 200% of the federal poverty level (FPL) and those above that level, and by whether they had no deductible, a low deductible (less than $1000 for an individual or $2400 for a family), or a high deductible (above $1000 for an individual or above $2400 for a family).
Compared to those with no deductible, privately insured persons with diabetes and a low deductible reported decreases in services: 27% fewer primary care visits, 39% fewer checkups, and 77% fewer specialty care visits. For those with a high deductible, the decline was even greater: the decreases were 42%, 65%, and 86%, respectively.
Among those with higher incomes, the decreases were highest for specialty care (28%) and emergency department visits (37%).
Diabetes care measures were similar by income and by insurance type; however, deferred service was twice as high for those who had medical debt and lower income. “These patients are more likely to report forgoing needed medical services,” the authors wrote.
The phenomenon of patients who end up in high-deductible plans that may not be appropriate for their medical needs is much discussed among those who care for patients with diabetes. This August, during a session on new payment models at the 2016 annual meeting of the American Association of Diabetes Educators, an attendee shared that her health system was requiring educators to bring up “bad debt” with patients during diabetes sessions, something that this professional felt was inappropriate.
What was needed, she said, was help for patients with diabetes to select benefit designs that were more appropriate for people who use a lot of medical care.
Reference
Rabin DL, Jetty A, Petterson S, Saqr Z, Froehlich A. Among low-income respondents with diabetes, high-deductible versus no-deductible insurance sharply reduces medical service use [published online December 12, 2016]. Diabetes Care. 2016; https://doi.org/10.2337/dc16-1579.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
December 20th 2024Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Read More